Welcome to LookChem.com Sign In|Join Free

CAS

  • or

6000-00-6

Post Buying Request

6000-00-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

6000-00-6 Usage

Description

METHYL 4-BROMOCROTONATE, also known as Methyl trans-4-bromo-2-butenoate, is a light yellow liquid with significant applications in the field of organic chemistry. It is primarily utilized as a key intermediate in the synthesis of various organic compounds, including benzoxepines, benzopyrans, and L-α-amino [4,5-3H]adipic acid.

Uses

Used in Pharmaceutical Industry:
METHYL 4-BROMOCROTONATE is used as a synthetic intermediate for the production of highly substituted benzoxepines and benzopyrans, which are important compounds in the development of pharmaceuticals. These compounds have potential applications in the treatment of various medical conditions due to their unique chemical structures and properties.
Used in Chemical Synthesis:
METHYL 4-BROMOCROTONATE is used as a reagent in the synthesis of several organic compounds, such as dimethoxy ketals and ketones. It plays a crucial role in the electrochemical oxidative decarboxylation of malonic acids, a process that is essential for the production of various chemicals with diverse applications.
Used in Research and Development:
METHYL 4-BROMOCROTONATE is also used in research and development laboratories for the synthesis of novel compounds and the exploration of new chemical reactions. Its unique properties make it a valuable tool for scientists working in the fields of organic chemistry and materials science.

Check Digit Verification of cas no

The CAS Registry Mumber 6000-00-6 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 6,0,0 and 0 respectively; the second part has 2 digits, 0 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 6000-00:
(6*6)+(5*0)+(4*0)+(3*0)+(2*0)+(1*0)=36
36 % 10 = 6
So 6000-00-6 is a valid CAS Registry Number.

6000-00-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name (E)-Methyl 4-bromobut-2-enoate

1.2 Other means of identification

Product number -
Other names Methyl trans-4-bromocrotonate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:6000-00-6 SDS

6000-00-6Relevant articles and documents

Ruthenium-catalyzed enantioselective C-H functionalization: A practical access to optically active indoline derivatives

Li, Zhong-Yuan,Lakmal, Hetti Handi Chaminda,Qian, Xiaolin,Zhu, Zhenyu,Donnadieu, Bruno,McClain, Sarah J.,Xu, Xue,Cui, Xin

supporting information, p. 15730 - 15736 (2019/10/11)

Ru(II)-catalyzed enantioselective C-H activation/hydroarylation has been developed for the first time, allowing for highly enantioselective synthesis of indoline derivatives via catalytic C-H activation. Commercially available Ru(II) arene complexes and chiral α-methylamines were employed as highly enantioselective catalysts. Based on a sterically rigidified chiral transient directing group, multisubstituted indolines were produced in up to 92% yield with 96% ee. Further transformation of the resulting 4-formylindoline enables access to an optically active tricyclic compound that is of potential biological and pharmaceutical interest.

Pyrazolopyrimidine derivative, preparation method, pharmaceutical composition and application

-

Paragraph 0249; 0250; 0251, (2017/07/19)

The invention discloses a pyrazolopyrimidine derivative, a preparation method, a pharmaceutical composition and application. The invention provides the pyrazolopyrimidine derivative as shown in a formula I and stereoisomer or solvate or pharmaceutically acceptable salts or active metabolite or prodrug thereof. The pyrazolopyrimidine derivative as shown in the formula I has good inhibitory activity on Bruton's tyrosine kinase (Btk) and particularly has good in vitro and in vivo inhibitory activity on growth of tumor cells, and a good marketization prospect is achieved. Please see the formula I in the description.

Tethered aminohydroxylation: Synthesis of the β-amino acid of microsclerodermins A and B

Pullin, Robert D. C.,Rathi, Akshat H.,Melikhova, Ekaterina Y.,Winter, Christian,Thompson, Amber L.,Donohoe, Timothy J.

supporting information, p. 5492 - 5495 (2013/11/19)

The utility of the tethered aminohydroxylation (TA) has been demonstrated by synthesis of the complex β-amino acid residue of microsclerodermins A and B. The TA provided a regio- and stereoselective functionalization of a complex homoallylic alcohol. The route includes late-stage introduction of the aliphatic side chain via a cuprate addition and cross metathesis, a tactic designed to render the synthesis applicable to other microsclerodermins.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 6000-00-6